Cronos Group Inc. (NASDAQ:CRON – Free Report) – Roth Capital boosted their FY2024 earnings estimates for shares of Cronos Group in a report released on Wednesday, November 13th. Roth Capital analyst W. Kirk now expects that the company will earn ($0.06) per share for the year, up from their prior estimate of ($0.08). The consensus estimate for Cronos Group’s current full-year earnings is ($0.05) per share.
Cronos Group Stock Down 2.9 %
Shares of NASDAQ:CRON opened at $2.01 on Friday. The stock has a market cap of $768.42 million, a PE ratio of -15.46 and a beta of 0.98. The company’s fifty day moving average is $2.17 and its 200 day moving average is $2.35. Cronos Group has a 52 week low of $1.85 and a 52 week high of $3.14.
Institutional Inflows and Outflows
Cronos Group Company Profile
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
Further Reading
- Five stocks we like better than Cronos Group
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Most Volatile Stocks, What Investors Need to Know
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Time to Load Up on Home Builders?
Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.